Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-032098
Filing Date
2024-02-12
Accepted
2024-02-12 16:22:58
Documents
2
Group Members
VACCINEX (ROCHESTER), L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d749313dsc13da.htm SC 13D/A 64895
2 EX-99.11 d749313dex9911.htm EX-99.11 23784
  Complete submission text file 0001193125-24-032098.txt   90093
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Subject) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90610 | Film No.: 24620289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1895 MOUNT HOPE AVENUE ROCHESTER NY 14620
Business Address
Zauderer Maurice (Filed by) CIK: 0001747753 (see all company filings)

Type: SC 13D/A